Meta-analysis of randomized controlled trials on atrial fibrillation ablation in patients with heart failure with reduced ejection fraction

Autor: Yousef Darrat, Alok Saurav, Hussam Abuissa, Amjad Kabach, Toufik Mahfood Haddad, Abdulghani Saadi, Mohsin Salih, Aiman Smer, Claude S. Elayi, Raviteja R. Guddeti, Mohamed Ayan
Rok vydání: 2018
Předmět:
Zdroj: Clinical Cardiology. 41:1430-1438
ISSN: 0160-9289
DOI: 10.1002/clc.23068
Popis: BACKGROUND: The role of catheter ablation (CA) is increasingly recognized as a reasonable therapeutic option in patients with atrial fibrillation (AF) and heart failure (HF). HYPOTHESIS: We aimed to compare CA to medical therapy in AF patients with HF with reduced ejection fraction (HFrEF). METHODS: We searched the literature for randomized clinical trials comparing CA to medical therapy in this population. RESULTS: Six trials with a total of 775 patients were included. AF was persistent in 95% of patients with a mean duration of 18.5 ± 23 months prior enrollment. The mean age was 62.2 ± 7.8 years, mostly males (83%) with mean left ventricular ejection fraction (LVEF) of 31.2 ± 6.7%. Compared to medical therapy, CA has significantly improved LVEF by 5.9% (Mean difference [MD] 5.93, confidence interval [CI] 3.59‐8.27, P
Databáze: OpenAIRE